Sept 29 (Reuters) – Metsera said on Monday that its experimental obesity drug showed significant weight loss and favorable tolerability in mid-stage studies. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Washington (dpa) - Many a pop song has nudged us to turn the lights down…
Berlin (dpa) - Doctors and scientists have been sounding the alarm as younger people prematurely develop conditions…
Berlin (dpa) - Having sudden, recurrent dizzy spells is quite stressful, and alarming if you…
जासूस और इन्वेस्टिगेटर बनने के इच्छुक युवाओं को व्यावहारिक जानकारी और सही दिशा देने का…
Berlin (dpa) - Germany's famed green sauce is a fabulously tasty combination of a specific…
As research shows parents are financing adult children until they’re at least 35, Lisa Salmon…